See analyst estimates and all valuation multiples for Small Molecules
Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
$3.6B | 8.0x | 20.8x | |
$3.2B | 18.0x | 57.4x | |
$2.4B | 3.1x | 17.7x | |
$2.3B | 20.9x | -31.1x | |
$2.2B | 88.0x | -64.4x | |
$1.8B | 0.7x | 5.7x | |
$1.8B | 11.8x | -6.1x | |
$1.6B | 6.3x | 15.7x | |
$1.2B | 5.3x | 15.6x | |
$1.2B | 5.4x | 26.3x | |
$929M | n/a | n/a | |
$867M | n/a | n/a | |
$841M | 4.2x | 17.8x | |
$778M | 3.6x | 87.0x | |
$673M | 7.9x | 22.3x | |
$375M | 5.0x | n/a | |
$339M | 133.7x | -1.9x | |
$327M | 1.7x | 8.7x | |
$240M | n/a | n/a | |
$167M | n/a | -7.7x | |
$158M | 6.0x | -6.6x | |
$153M | 3.3x | n/a | |
$131M | 2975.2x | -30.0x | |
$122M | 1.3x | -12.4x | |
$101M | 1.8x | -1.4x | |
$26.2M | n/a | -0.2x | |
-$5.7M | -0.2x | n/a | |
-$25.9M | -0.3x | 0.3x | |
-$30.9M | -7.5x | n/a | |
-$39.5M | n/a | n/a | |
-$62.0M | -2.0x | 0.6x | |
-$96.9M | n/a | 0.8x | |
-$206M | -5.2x | 1.1x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules